跳至主要内容
临床试验/JPRN-jRCT1031220254
JPRN-jRCT1031220254尚未招募未知

The antiplatelet function of prasugrel and clopidogrel assessed by the light transmission aggregometry in patients with stable coronary artery disease

Isoda Kikuo0 个研究点目标入组 100 人开始时间: 2022年8月8日最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Age is 20 years or older at the time of consent acquisition
  • 2) Those who are judged by the doctor in charge to be DAPT indicated due to PCI schedule for stable coronary artery disease
  • 3) Maintenance of aspirin (100 mg / day) as part of standard treatment
  • 4) Those who have received sufficient explanation before participating in this research, and who have obtained sufficient understanding and voluntary written consent of the research subject

排除标准

  • 1) Platelet count<50000000000/L
  • 2) Dialysis patients
  • 3) Baseline ALT> 2.5 times the normal upper limit.
  • 4) Pregnant or lactating women
  • 5) Contraindications for prasugrel, clopidogrel, or stent placement
  • 6) In addition, those who are judged by the principal investigator to be inappropriate as research subjects

研究者

发起方
Isoda Kikuo

相似试验